|
廣州白雲山醫藥集團股份有限公司 - H股, 00874.HK - 綜合損益表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
營業額 |
75,515,404 |
70,788,155 |
69,014,052 |
61,673,702 |
64,951,778 |
42,233,838 |
20,954,225 |
20,035,681 |
19,124,658 |
18,818,232 |
17,608,193 |
12,062,642 |
5,439,612 |
4,403,098 |
3,802,423 |
3,450,586 |
11,873,514 |
10,241,004 |
9,026,340 |
經營溢利 |
5,120,897 |
5,074,400 |
4,786,042 |
3,672,416 |
4,055,012 |
3,835,954 |
2,460,971 |
1,466,625 |
1,410,336 |
1,342,231 |
1,120,074 |
855,316 |
308,926 |
227,861 |
102,214 |
109,997 |
455,474 |
349,434 |
316,705 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2,196 |
-1,220 |
-7,814 |
-61,829 |
0 |
0 |
聯營公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
109,650 |
134,174 |
106,369 |
56,065 |
-279 |
-1,212 |
除稅前經營溢利 |
5,110,498 |
5,043,244 |
4,723,071 |
3,739,082 |
4,128,533 |
4,018,730 |
2,492,976 |
1,945,053 |
1,628,122 |
1,468,061 |
1,229,190 |
881,063 |
334,993 |
339,707 |
235,168 |
208,552 |
449,710 |
349,155 |
315,493 |
稅項 |
851,170 |
789,874 |
754,085 |
647,454 |
687,246 |
485,014 |
374,221 |
386,379 |
282,835 |
256,533 |
222,243 |
114,365 |
34,996 |
51,847 |
22,491 |
37,256 |
119,859 |
118,567 |
107,771 |
少數股東權益 |
203,649 |
286,848 |
249,108 |
176,383 |
252,403 |
92,736 |
57,104 |
50,641 |
44,936 |
17,387 |
26,902 |
37,657 |
12,466 |
8,263 |
-2,223 |
-10,533 |
9,508 |
12,521 |
9,918 |
股東應占溢利 |
4,055,679 |
3,966,522 |
3,719,878 |
2,915,245 |
3,188,885 |
3,440,980 |
2,061,652 |
1,508,033 |
1,300,351 |
1,194,141 |
980,045 |
729,040 |
287,531 |
279,597 |
214,900 |
181,829 |
320,343 |
218,067 |
197,804 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
985,039 |
743,828 |
676,992 |
679,265 |
625,608 |
440,276 |
83,348 |
80,268 |
223,869 |
203,709 |
181,615 |
181,866 |
107,725 |
109,800 |
114,985 |
119,492 |
3,291 |
145,428 |
125,389 |
利息 |
446,192 |
434,408 |
417,831 |
363,344 |
374,224 |
222,801 |
6,823 |
20,684 |
21,938 |
1,394 |
44,504 |
61,022 |
5,825 |
1,544 |
8,062 |
10,197 |
56,936 |
55,113 |
51,338 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1,519 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
16.66 |
15.66 |
15.97 |
17.32 |
16.65 |
12.07 |
15.01 |
19.86 |
17.37 |
17.47 |
18.08 |
12.98 |
10.45 |
15.26 |
9.56 |
17.86 |
26.65 |
33.96 |
34.16 |
營業額增長(%) |
6.68 |
2.57 |
11.9 |
-5.05 |
53.79 |
101.55 |
4.58 |
4.76 |
1.63 |
6.87 |
45.97 |
121.76 |
23.54 |
15.8 |
10.2 |
-70.94 |
15.94 |
13.46 |
17.08 |
股東應占溢利增長(%) |
2.25 |
6.63 |
27.6 |
-8.58 |
-7.33 |
66.9 |
36.71 |
15.97 |
8.89 |
21.85 |
34.43 |
153.55 |
2.84 |
30.11 |
18.19 |
-43.24 |
46.9 |
10.24 |
361.85 |
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|